Feasibility of [<sup>18</sup>F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type <i>KRAS</i> Colorectal Cancer

Feasibility of [<sup>18</sup>F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type <i>KRAS</i> Colorectal Cancer

Early response assessment is critical for personalizing cancer therapy. Emerging therapeutic regimens with encouraging results in the wild-type (WT) <i>KRAS</i> colorectal cancer (CRC) setting include inhibitors of epidermal growth factor receptor (EGFR) and glutaminolysis. Towards predi...

Full description

Bibliographic Details
Main Authors: Seong-Woo Bae, Jianbo Wang, Dimitra K. Georgiou, Xiaoxia Wen, Allison S. Cohen, Ling Geng, Mohammed Noor Tantawy, H. Charles Manning
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Tomography
Subjects:
PET
FSPG
glutaminolysis
EGFR
colorectal cancer
Online Access:https://www.mdpi.com/2379-139X/9/2/41

Internet

https://www.mdpi.com/2379-139X/9/2/41

Similar Items